about
Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells.Applications of Copolymeric Nanoparticles in Drug Delivery Systems.Biodegradable m-PEG/PCL Core-Shell Micelles: Preparation and Characterization as a Sustained Release Formulation for Curcumin.LC-MS Method for Studying the Pharmacokinetics and Bioequivalence of Clonidine Hydrochloride in Healthy Male Volunteers.Simple and Sensitive High-Performance Liquid Chromatography (HPLC) Method with UV Detection for Mycophenolic Acid Assay in Human Plasma. Application to a Bioequivalence Study.PLA-PEG-PLA copolymer-based polymersomes as nanocarriers for delivery of hydrophilic and hydrophobic drugs: preparation and evaluation with atorvastatin and lisinopril.Drug-conjugated PLA-PEG-PLA copolymers: a novel approach for controlled delivery of hydrophilic drugs by micelle formationPreparation, characterization, and evaluation of amino acid modified magnetic nanoparticles: drug delivery and MRI contrast agent applicationsStudy of Copolymer Composition on Drug Loading Efficiency of Enalapril in Polymersomes and Cytotoxicity of Drug Loaded NanoparticlesIn vivo study of mPEG-PCL as a nanocarriers for anti-inflammatory drug delivery of simvastatinFacile green synthesis of bismuth sulfide radiosensitizer via biomineralization of albumin natural molecule for chemoradiation therapy aimBiotin-functionalized copolymeric PEG-PCL micelles for in vivo tumour-targeted delivery of artemisininAnti-inflammatory effect of rosuvastatin using diblock amphiphilic copolymer: Synthesis, characterization, in vitro and in vivo studyIn vivo and In vitro Biocompatibility Study of MnFe2O4 and Cr2Fe6O12 as Photosensitizer for Photodynamic Therapy and Drug Delivery of Anti-Cancer Drugs
P50
Q38790956-E23ED78B-B474-4428-BF2E-C55C7ECFB9B2Q38893640-45CB3BEE-D862-4469-A1B4-3F3E3D1F9DF8Q39041076-604FC82E-53C8-409D-9E7B-109C02570EAAQ40537990-0F2E6F1A-4CC9-48D3-BAD7-667EDB09C0CFQ42052503-6B833440-8F92-47FA-9530-53199D670B90Q43501935-64A59C17-7812-4901-BC3F-7BAE55DF1052Q57182105-1B87AE2A-671F-4F90-BCA5-2F2ED6A564B6Q57465365-983349BB-486A-4979-A711-64E59879F155Q87944229-80BB868E-168C-470F-802C-50E86A81DB6EQ90270533-00032936-5A10-483A-B4B3-0D245C4B78F6Q90299096-848445CD-BE0A-4041-8CDD-86B29C371DD4Q91136312-6F2051A2-F893-405A-B65D-AB4E688CD5D7Q91746740-9F5CA00A-2875-4BE9-A0B7-F8ACC5CAE088Q92010971-A6E08D1D-24B6-4CF2-9B5E-86CC8D7AECDD
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
H Danafar
@en
H Danafar
@nl
type
label
H Danafar
@en
H Danafar
@nl
prefLabel
H Danafar
@en
H Danafar
@nl
P31
P496
0000-0001-8956-7895